Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-01-24 @ 9:01 PM
Study NCT ID:
NCT03400033
Status:
COMPLETED
Last Update Posted:
2021-07-12
First Post:
2018-01-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Sponsor:
GlaxoSmithKline
Organization: